Halofuginone: a potent inhibitor of critical steps in angiogenesis progression

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The FASEB Journal

• Publication date

  2000-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1096/fj.00-0292comPMID 11099465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticancer drug targets: approaching angiogenesis.

  1999cited by this paper
• Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.

  1999influential reference
• Tumor angiogenesis—new drugs on the block

  1999cited by this paper
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

  1999cited by this paper
• Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.

  1999cited by this paper
• Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor.

  1999cited by this paper
• Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.

  1999cited by this paper
• Endothelial cell adherence to small intestinal submucosa: an acellular bioscaffold.

  1999influential reference
• Small Intestinal Submucosa: A Tissue-Derived Extracellular Matrix That Promotes Tissue-Specific Growth and Differentiation of Cells in Vitro

  1998cited by this paper
• Small intestinal submucosa: a substrate for in vitro cell growth.

  1998cited by this paper
• Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

  1998cited by this paper
• Halofuginone: a novel antifibrotic therapy.

  1998cited by this paper
• Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone.

  1997influential reference
• Geometric control of cell life and death.

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.

  1997influential reference
• Regulation of capillary formation by laminin and other components of the extracellular matrix.

  1997cited by this paper
• Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone.

  1996cited by this paper
• A model of angiogenesis in the mouse cornea.

  1996cited by this paper
• Differentiation of endothelium

  1995cited by this paper
• Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.

  1994cited by this paper
• Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds.

  1994cited by this paper
• The implications of angiogenesis for the biology and therapy of cancer metastasis.

  1994cited by this paper
• Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro

  1993influential reference
• Halofuginone: an inhibitor of collagen type I synthesis.

  1993cited by this paper
• Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells.

  1993cited by this paper
• Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis

  1991cited by this paper
• Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium.

  1991influential reference
• Regulation of angiogenesis in vitro by collagen metabolism

  1991cited by this paper
• Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone.

  1991cited by this paper
• Differential expression of extracellular proteins is correlated with angiogenesis in vitro.

  1991cited by this paper
• Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro.

  1991influential reference
• Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro.

  1990cited by this paper
• Molecular architecture of basement membranes

  1990cited by this paper
• What is the evidence that tumors are angiogenesis dependent?

  1990cited by this paper
• Inhibition of angiogenesis through modulation of collagen metabolism.

  1988cited by this paper
• A rapid in vitro assay for quantitating the invasive potential of tumor cells.

  1987influential reference
• Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

  1986cited by this paper
• Partial purification and characterization of a neutral protease which cleaves type IV collagen.

  1981cited by this paper
• The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells.

  1980cited by this paper
• Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.

  1976cited by this paper
• Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors

  1972cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• Aromatic Amine attached Quinazolinones: Synthesis Characterization and DNA Binding Properties

  2024cites this paper
• Halofuginone ameliorates systemic lupus erythematosus by targeting Blk in myeloid-derived suppressor cells.

  2023cites this paper
• Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia

  2022cites this paper
• Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis

  2022cites this paper
• Characterization of the activity and the mechanism of action of a new toluquinol derivative with improved potential as an antiangiogenic drug.

  2022cites this paper
• Targeting the integrated stress response in ophthalmology

  2021cites this paper
• Indoxyl sulfate impairs angiogenesis via chronic aryl hydrocarbon receptor activation.

  2021cites this paper
• Halofuginone, a promising drug for treatment of pulmonary hypertension

  2021cites this paper
• Halofuginone inhibits LPS-induced attachment of monocytes to HUVECs.

  2020cites this paper
• Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway.

  2020cites this paper
• The strigolactone analog GR-24 inhibits angiogenesis in vivo and in vitro by a mechanism involving cytoskeletal reorganization and VEGFR2 signalling.

  2019cites this paper
• Exploring the Antiangiogenic Potential of Solomonamide A Bioactive Precursors: In Vitro and In Vivo Evidences of the Inhibitory Activity of Solo F-OH During Angiogenesis

  2019cites this paper
• Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis

  2019cites this paper
• COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS

  2018influential citation
• Positive‐Feedback Regulation of Subchondral H‐Type Vessel Formation by Chondrocyte Promotes Osteoarthritis Development in Mice

  2018cites this paper
• Exogenous FGF-2 improves biological activity of endothelial progenitor cells exposed to high glucose conditions

  2018cites this paper
• Halofuginone: a novel oral and intravesical agent for the treatment of non-muscle invasive bladder cancer

  2018cites this paper
• Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage

  2018cites this paper
• Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts

  2017cites this paper
• Halofuginone inhibits TNF‐&agr;‐induced the migration and proliferation of fibroblast‐like synoviocytes from rheumatoid arthritis patients

  2017cites this paper
• The integrated stress response

  2016cites this paper
• Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

  2015cites this paper
• Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone

  2015cites this paper
• Halofuginone Prevents the Progression of Osteoarthritis

  2015cites this paper
• Febrifugine and its analogs: studies for their antimalarial and other therapeutic properties

  2015cites this paper
• Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model

  2015cites this paper
• Halofuginone — The Multifaceted Molecule

  2015cites this paper
• New molecular medicine-based scar management strategies.

  2014cites this paper
• The Effect of Antifibrotic Drug Halofugine on Th17 Cells in Concanavalin A‐Induced Liver Fibrosis

  2014cites this paper
• The chemistry and biology of febrifugine and halofuginone.

  2014cites this paper
• Plant-derived anticancer agents: a promising treatment for bone metastasis.

  2014cites this paper
• Halofuginone Ameliorates Autoimmune Arthritis in Mice by Regulating the Balance Between Th17 and Treg Cells and Inhibiting Osteoclastogenesis

  2013cites this paper
• Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary

  2013cites this paper
• Insilico Screening, Validation and Elucidation of Mechanism of Action of Novel Aglycones against Angiogenesis Targets using AutoDock Tools 4.0

  2013cites this paper
• Antiangiogenic Alkaloids from Plants

  2013cites this paper
• Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects.

  2013cites this paper
• Exploitation of in silico potential in prediction, validation and elucidation of mechanism of anti-angiogenesis by novel compounds: comparative correlation between wet lab and in silico data

  2013influential citation
• Local inhibition of angiogenesis by halofuginone coated silicone materials

  2012cites this paper
• Halofuginone inhibits the establishment and progression of melanoma bone metastases.

  2012cites this paper
• Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor

  2012cites this paper
• Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents

  2012cites this paper
• Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation

  2012cites this paper
• Surgical Stress Resistance Induced by Single Amino Acid Deprivation Requires Gcn2 in Mice

  2012cites this paper
• The In Vitro Endothelial Cell Tube Formation Assay in 3D Culture on Gelled Basement Membrane Extract

  2012cites this paper
• Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi Sarcoma

  2011cites this paper
• Halofuginone Has Anti-Proliferative Effects in Acute Promyelocytic Leukemia by Modulating the Transforming Growth Factor Beta Signaling Pathway

  2011cites this paper
• Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis

  2011cites this paper
• Antiangiogenic properties of Boerhaavia diffusa extracts in chick Chorioallantoic Membrane (CAM)

  2011cites this paper
• Pharmacological management of Kaposi's sarcoma

  2011cites this paper
• Microarray profiling reveals the integrated stress response is activated by halofuginone in mammary epithelial cells

  2011cites this paper
• Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development

  2010cites this paper
• In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract

  2010cites this paper
• Halofuginone enhances the radiation sensitivity of human tumor cell lines.

  2010cites this paper
• Halofuginone, a Specific Inhibitor of Collagen Type 1 Synthesis, Ameliorates Oxidant Colonic Damage in Rats with Experimental Colitis

  2010cites this paper
• Expression of MMP, HPSE, and FAP in Stroma Promoted Corneal Neovascularization Induced by Different Etiological Factors

  2010cites this paper
• Bmc Complementary and Alternative Medicine Anti-angiogenic Effects of Pterogynidine Alkaloid Isolated from Alchornea Glandulosa

  2009cites this paper
• The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art

  2009cites this paper
• Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases

  2009cites this paper
• Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: Are two applications better than one?

  2009cites this paper
• The Effect of Porous Poly-L-Lactic Acid Coatings on Tissue Response and Subsequent Glucose Sensor Performance

  2009cites this paper
• Treatment of pediatric brain tumors

  2008cites this paper
• DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo

  2008cites this paper
• The preventive effect of halofuginone on posterior glottic stenosis in a rabbit model

  2008cites this paper
• Design Genetic Fluorescent Probes to Detect Protease Activity and Calcium-Dependent Protein-Protein Interactions in Living Cells

  2008cites this paper
• Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone

  2008cites this paper
• Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment

  2007cites this paper
• Potential therapeutical effects of topical halofuginone hydrobromide in keloid management.

  2007cites this paper
• Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect

  2007cites this paper
• Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma

  2007influential citation
• IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo

  2007cites this paper
• IB 05204 , a dichloropyridodithienotriazine , inhibits angiogenesis in vitro and in vivo

  2007cites this paper
• Molecular targets in metastasis: lessons from genomic approaches.

  2007cites this paper
• Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours.

  2006cites this paper
• Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.

  2006cites this paper
• Halofuginone inhibits NF‐κB and p38 MAPK in activated T cells

  2006cites this paper
• Tumor stroma and regulation of cancer development.

  2006cites this paper
• Anti‐angiogenic drugs: from bench to clinical trials

  2006cites this paper
• Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism

  2006cites this paper
• Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.

  2006cites this paper
• Halofuginone Prevents Subglottic Stenosis in a Canine Model

  2006cites this paper
• Prevention of Intra-abdominal Adhesions Using the Antiangiogenic COX-2 Inhibitor Celecoxib

  2005cites this paper
• Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expression.

  2005cites this paper
• Stromal responses in human primary melanoma of the skin.

  2005cites this paper
• Inhibition of breast adenocarcinoma growth by intratumoral injection of lipophilic long-acting lathyrogens.

  2005cites this paper
• Angiogenesis "in vitro" of the healthy mouse heart under hypoxia : the role of Angiotensin II and Nitric Oxide

  2005cites this paper
• Heparanase Induces Endothelial Cell Migration via Protein Kinase B/Akt Activation*

  2004cites this paper
• A versatile in vitro assay for investigating angiogenesis of the heart.

  2004cites this paper
• Cancer anti-angiogenic therapy.

  2004cites this paper
• Target Selection Issues in Drug Discovery and Development

  2004cites this paper
• Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma.

  2004cites this paper
• Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma

  2004cites this paper
• Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study.

  2004cites this paper
• Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.

  2004cites this paper
• Drug therapies for uterine fibroids: a new approach to an old problem

  2004cites this paper
• Liposomes with selective and controllable surface reactivity : applications for tumor specific thrombosis

  2003cites this paper
• The tumor microenvironment: a critical determinant of neoplastic evolution.

  2003cites this paper
• Vivo in Inhibition of a von Hippel-Lindau Pheochromocytoma Treatment with Halofuginone Results in Marked Growth

  2003cites this paper
• Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.

  2003cites this paper
• Drug inhibition of angiogenesis.

  2002cites this paper
• Anti-angiogenic effects of homocysteine on cultured endothelial cells.

  2002cites this paper